Irvingia Gabonensis + Atogepant

This is not an interaction. Neither one changes how your body handles the other, and nothing here says they react together. What our sources do show is that each has separately been linked to the effects below — so taking both can make those effects more likely to turn up, and harder to pin on one or the other if they do.

• Tiredness reported in 6.5% of FDA reports for Atogepant Additional detail

  Irvingia Gabonensis

  “One case of acute hepatitis secondary to Irvingia gabonensis has been reported. A 45-year old male with a ten-day history of Irvingia gabonensis supplementation, at a dose of 350 mg of seed extract twice daily for body fat reduction, was admitted with jaundice, abdominal discomfort, and new onset malaise. His complaints began four days after starting Irvingia gabonensis supplementation.”

  Irvingia Gabonensis · Natural Medicines adverse-effect record, reported in alcohol-related liver disease.

  1 source cited

  1. 92824. Kilinçalp S, Basar O, Coban S, Yüksel I. Irvingia gabonensis (African mango): innocent magic formula? Acta Gastroenterol Belg 2014;77(1):75-6.

  Atogepant

  Listed in the ADVERSE REACTIONS section of the FDA label for Atogepant, and in voluntary FDA adverse-event reports. Read the label on DailyMed ›

• Nausea reported in 9.2% of FDA reports for Atogepant Additional detail

  Irvingia Gabonensis

  “Flatulence has been reported following 10 weeks of supplementation with Irvingia gabonensis alone or in combination with Cissus quadrangularis. Similar events were observed in controls. Mild nausea has also been reported following the administration of Irvingia gabonensis 0.3-4 grams daily for up to 12 weeks; however, some of these symptoms were alleviated by the addition of milk to the test preparation.”

  Irvingia Gabonensis · Natural Medicines adverse-effect record, reported in flatulence.

  4 sources cited

  1. 17070. Ngondi JL, Etoundi BC, Nyangono CB, et al. IGOB131, a novel seed extract of the West African plant Irvingia gabonensis, significantly reduces body weight and improves metabolic parameters in overweight humans in a randomized double-blind placebo controll
  2. 16457. Oben JE, Ngondi JL, Momo CN, et al. The use of Cissus quadrangularis/Irvingia gabonensis combination in the management of weight loss: a double-blind placebo-controlled study. Lipids Health Dis 2008;7:12.
  3. 61589. Adamson, I., Okafor, C., and Abu-Bakare, A. A supplement of Dikanut (Irvingia gabonesis) improves treatment of type II diabetics. West Afr.J.Med. 1990;9(2):108-115.
  4. 112220. Nonsa-Ard R, Aneknan P, Tong-Un T, Honsawek S, Leelayuwat N. Effects of Irvingia gabonensis Extract on Metabolism, Antioxidants, Adipocytokines, Telomere Length, and Aerobic Capacity in Overweight/Obese Individuals. Nutrients 2022;14(21):4646. PubMed ↗

  Atogepant

  Listed in the ADVERSE REACTIONS section of the FDA label for Atogepant, and in voluntary FDA adverse-event reports. Read the label on DailyMed ›

Reported for Irvingia Gabonensis but not commonly for Atogepant: stomach upset, bloating or gas, liver problems and headache.

Effects for Atogepant come from the ADVERSE REACTIONS section of its FDA label; effects for Irvingia Gabonensis come from the Natural Medicines adverse-effect record, quoted above. Where a percentage is shown, it is the share of 6,568 voluntary FDA FAERS reports for Atogepant that mention that effect — a reporting proportion, not an incidence rate and not evidence the drug caused it. Wording is matched across sources by our own clinical vocabulary, so treat this as a prompt to pay attention, not a diagnosis.